Royalty Pharma total depreciation and amortization - cash flow for the twelve months ending March 31, 2025 was $0.048B, a 6.15% decline year-over-year.
Royalty Pharma annual total depreciation and amortization - cash flow for 2024 was $0.02B, a 4.57% decline from 2023.
Royalty Pharma annual total depreciation and amortization - cash flow for 2023 was $0.02B, a 24.15% decline from 2022.
Royalty Pharma annual total depreciation and amortization - cash flow for 2022 was $0.027B, a 37.38% decline from 2021.
Royalty Pharma Total Depreciation and Amortization - Cash Flow 2019-2025 | RPRX